Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bi-853520
2. In10018
3. Chembl3657311
4. Schembl12135026
5. Bdbm134067
6. Ex-a6297
7. Bi853520
8. In-10018
9. Hy-122844
10. Cs-0089968
11. Us8846689, 69
12. 1227948-82-4
13. 2-fluoro-5-methoxy-4-[[4-[(2-methyl-3-oxo-1h-isoindol-4-yl)oxy]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-n-(1-methylpiperidin-4-yl)benzamide
| Molecular Weight | 588.6 g/mol |
|---|---|
| Molecular Formula | C28H28F4N6O4 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 109 |
| Heavy Atom Count | 42 |
| Formal Charge | 0 |
| Complexity | 954 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Ifebemtinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ifebemtinib, including repackagers and relabelers. The FDA regulates Ifebemtinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ifebemtinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ifebemtinib supplier is an individual or a company that provides Ifebemtinib active pharmaceutical ingredient (API) or Ifebemtinib finished formulations upon request. The Ifebemtinib suppliers may include Ifebemtinib API manufacturers, exporters, distributors and traders.
Ifebemtinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ifebemtinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ifebemtinib GMP manufacturer or Ifebemtinib GMP API supplier for your needs.
A Ifebemtinib CoA (Certificate of Analysis) is a formal document that attests to Ifebemtinib's compliance with Ifebemtinib specifications and serves as a tool for batch-level quality control.
Ifebemtinib CoA mostly includes findings from lab analyses of a specific batch. For each Ifebemtinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ifebemtinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Ifebemtinib EP), Ifebemtinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ifebemtinib USP).
LOOKING FOR A SUPPLIER?
